Stocks · News reference

RBC Capital Maintains Outperform on Extendicare, Raises Price Target to C$39

Aug 14, 2026, 3:48 PMBenzinga Newsdesk

RBC Capital analyst Pammi Bir maintains Extendicare (TSX:EXE) with a Outperform and raises the price target from C$38 to C$39.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaAug 6, 2026, 9:40 PMBenzinga Newsdesk
Extendicare Q2 EPS $0.32 Misses $0.39 Estimate, Sales $611.040M Beat $547.200M Estimate
Extendicare (TSX:EXE) reported quarterly earnings of $0.32 per share which missed the analyst consensus estimate of $0.39 by 17.95 percent. This is a 13.51 percent decrease over earnings of $0.37 per share from the same
Read original at benzinga
TSX:EXE